Published in Curr Probl Surg on November 01, 1983
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81
Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology (1991) 1.30
Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc (1992) 1.26
The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation (1991) 1.24
Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc (1990) 1.14
Liver transplantation in patients with patent splenorenal shunts. Surgery (1987) 1.12
Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology (1992) 0.89
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88
Current status of intestinal transplantation. Adv Surg (1994) 0.78
Intestinal transplantation. Annu Rev Med (1994) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Lancet (1983) 0.78
Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. Transplantation (1991) 0.76
The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75
Survival of human hepatocellular aggregates in athymic mice. Transplant Proc (1992) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
The Problem of Portal Hypertension in Relation to the Hepatosplenopathies. Ann Surg (1945) 13.38
RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION. J Exp Med (1920) 10.36
The Technic of Using Vitallium Tubes in Establishing Portacaval Shunts for Portal Hypertension. Ann Surg (1945) 9.38
Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem (1974) 9.02
Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg (1967) 5.62
Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med (1969) 5.40
Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia. J Clin Invest (1954) 4.78
IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann Surg (1964) 4.14
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg (1973) 3.44
Liver regeneration following portacaval transposition in dogs. Ann Surg (1953) 3.23
Ammonia metabolism in man. Ann Surg (1954) 3.16
An investigation of the relationship between portal venous pressure and inferior vena caval and portal venous oxygen saturations. Ann Surg (1957) 3.16
Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. Proc Natl Acad Sci U S A (1975) 3.16
PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION. Surg Gynecol Obstet (1965) 3.15
Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes (1970) 3.12
Peritoneo-venous shunting for ascites. Ann Surg (1974) 2.87
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci U S A (1981) 2.82
Hyperglobulinaemia in liver disease. Lancet (1973) 2.74
A clarification of some hemodynamic changes in cirrhosis and their surgical significance. Ann Surg (1959) 2.74
Immunological unresponsiveness produced in adult guinea pigs by parenteral introduction of minute quantities of hapten or protein antigen. Proc Soc Exp Biol Med (1962) 2.68
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest (1975) 2.65
Management of extrahepatic portal hypertension in children. Ann Surg (1974) 2.48
A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg (1971) 2.46
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature (1967) 2.35
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Carcinoma of the head of the pancreas: resection of the portal vein and portacaval shunt. Ann Surg (1958) 2.27
A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med (1969) 2.19
A randomized, controlled trial of the distal splenorenal shunt. Ann Surg (1978) 2.15
Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg (1965) 2.10
Immunogenic sub-cellular particles obtained from spleens of antigen-injected mice. Nature (1962) 2.06
A controlled study of the therapeutic portacaval shunt. Gastroenterology (1974) 2.05
Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00
Prophylactic portacaval anastomosis. Medicine (Baltimore) (1972) 1.99
Selectivity of the distal splenorenal shunt. Surgery (1979) 1.92
The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91
Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting. Arch Surg (1973) 1.91
Studies of hepatic function in dogs with Eck fistula or portacaval transposition. AMA Arch Surg (1957) 1.90
Interposition mesocaval shunt for treatment of portal hypertension. Ann Surg (1972) 1.85
Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg (1982) 1.78
Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74
Angiography in portal hypertension: clinical significance in surgery. Am J Surg (1980) 1.72
A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg (1968) 1.72
THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS. Surgery (1965) 1.66
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
Portacaval shunt in the rat. Surgery (1961) 1.65
Some effects upon the liver of complete arterialization of its blood supply. Surgery (1952) 1.64
Fine structural and growth characteristics of cultured rat liver cells. Insulin effects. Exp Cell Res (1972) 1.63
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
Physical-chemical basis of lipid deposition in atherosclerosis. Science (1974) 1.63
Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med (1974) 1.58
Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54
Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis (1977) 1.52
Effect of increased hepatic blood flow upon liver regeneration. AMA Arch Surg (1954) 1.50
A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet (1976) 1.49
Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg (1974) 1.43
Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg (1979) 1.41
Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. J Pharmacol Exp Ther (1976) 1.41
Hepatotrophic substances. Prog Liver Dis (1979) 1.39
A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices. Surgery (1979) 1.38
Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins. Proc Natl Acad Sci U S A (1982) 1.35
The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34
The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33
An electron microscopic study of lipoprotein production and release by the isolated perfused rat liver. Proc Soc Exp Biol Med (1966) 1.33
Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization. Immunology (1973) 1.30
Portal obstruction in children. II. Results of surgical portosystemic shunts. J Pediatr (1983) 1.26
Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med (1946) 1.24
Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals. Postgrad Med J (1974) 1.24
Physiological processes and dynamics in the disposition of small and large doses of biologically active and inactive 131-I-insulins in the rat. J Biol Chem (1967) 1.23
Results of a modified distal spleno-renal shunt for portal hypertension. Ann Surg (1977) 1.22
Portacaval transposition in the treatment of glycogen-storage disease. Lancet (1966) 1.21
A prospective randomized trial of the selective distal splenorenal shunt. Surg Gynecol Obstet (1980) 1.20
Extrahepatic portal hypertension: a retrospective analysis. Ann Surg (1979) 1.20
Liver transplantation for type I glycogen storage disease. Lancet (1983) 1.20
ULTRASTRUCTURAL HEPATIC CHANGES FOLLOWING PARTIAL HEPATECTOMY AND PORTACAVAL SHUNT IN THE RAT. Lab Invest (1963) 1.19
The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts. Ann Surg (1974) 1.19
Hemodynamic variables and prognosis following portacaval shunts. Surg Gynecol Obstet (1974) 1.18
Extraction of insulin by liver. Annu Rev Med (1973) 1.16
Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology (1981) 1.15
HOMOTRANSPLANTATION OF THE CANINE LIVER: SURVIVAL AND HISTOLOGY WITH AND WITHOUT AZATHIOPRINE. Arch Surg (1965) 1.15
Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg (1976) 1.11
LIVER CELL DAMAGE PRODUCED BY PORTACAVAL SHUNTS. Proc Soc Exp Biol Med (1965) 1.11
The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet (1978) 1.11
Rate constants for the uptake of cholesterol from various intestinal and serum lipoprotein fractions by the liver of the rat in vivo. Biochim Biophys Acta (1977) 1.10
Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates. Ann Surg (1980) 1.09
Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery. Surgery (1972) 1.09
Infantile cirrhosis with hereditary alpha 1 -antitrypsin deficiency. Clinical improvement in two siblings. Am J Dis Child (1973) 1.09
Noncirrhotic portal vein thrombosis. Physiology before and after shunts. Ann Surg (1980) 1.08
Influence of blood supply on regeneration of liver transplants. Surg Forum (1969) 1.08
ENHANCED ANTIBODY FORMATION IN EXPERIMENTAL ACUTE AND CHRONIC LIVER INJURY PRODUCED BY CARBON TETRACHLORIDE OR ALLYL ALCOHOL. Proc Soc Exp Biol Med (1965) 1.07
Control of the hyperdynamic circulation in patients with bleeding esophageal varices. Ann Surg (1969) 1.07
LIVER DEGLYCOGENATION AFTER PORTACAVAL TRANSPOSITION. Surg Forum (1964) 1.07
Results of left gastric vena caval shunt for esophageal varices: Analysis of one hundred clinical cases. Surgery (1975) 1.06
Risks in therapeutic portacaval and splenorenal shunts. Ann Surg (1976) 1.06
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92